In conclusion, we present a case of ALK + LBCL with aberrant expression of CD3 and gene rearrangement of both IGH and TCR. A panel of immunohistochemistry markers including multiple T cell, B cell, and plasmacytic markers was necessary to characterize the lymphoma, which is recommended when lineage-specific antigen expression is ambiguous. The gene discussed is ALK; the disease is lymphoma.